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Abstract
Background: Enterohemorrhagic Escherichia coli (EHEC) O26:H11/H−, the most common non-O157 serotype
causing hemolytic uremic syndrome worldwide, are evolutionarily highly dynamic with new pathogenic clones
emerging rapidly. Here, we investigated the population structure of EHEC O26 isolated from patients in several
European countries using whole genome sequencing, with emphasis on a detailed analysis of strains of the highly
virulent new European clone (nEC) which has spread since 1990s.
Results: Genome-wide single nucleotide polymorphism (SNP)-based analysis of 32 EHEC O26 isolated in the Czech
Republic, Germany, Austria and Italy demonstrated a split of the nEC (ST29C2 clonal group) into two distinct lineages,
which we termed, based on their temporal emergence, as “early” nEC and “late” nEC. The evolutionary divergence of
the early nEC and late nEC is marked by the presence of 59 and 70 lineage-specific SNPs (synapomorphic mutations) in
the genomes of the respective lineages. In silico analyses of publicly available E. coli O26 genomic sequences identified
the late nEC lineage worldwide. Using a PCR designed to target the late nEC synapomorphic mutation in the sen/ent
gene, we identified the early nEC decline accompanied by the late nEC rise in Germany and the Czech Republic since
2004 and 2013, respectively. Most of the late nEC strains harbor one of two major types of Shiga toxin 2a (Stx2a)-
encoding prophages. The type I stx2a-phage is virtually identical to stx2a-phage of EHEC O104:H4 outbreak strain,
whereas the type II stx2a-phage is a hybrid of EHEC O104:H4 and EHEC O157:H7 stx2a-phages and carries a novel
mutation in Stx2a. Strains harboring these two phage types do not differ by the amounts and biological activities
of Stx2a produced.
Conclusions: Using SNP-level analyses, we provide the evidence of the evolutionary split of EHEC O26:H11/H− nEC into
two distinct lineages, and a recent replacement of the early nEC by the late nEC in Germany and the Czech Republic. PCR
targeting the late nEC synapomorphic mutation in ent/sen enables the discrimination of early nEC strains and late nEC
strains in clinical and environmental samples, thereby facilitating further investigations of their geographic distribution,
prevalence, clinical significance and epidemiology.
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Background
Enterohemorrhagic Escherichia coli (EHEC) O26:H11/
H− is the most common non-O157 EHEC serotype caus-
ing diarrhea and its systemic complication, the hemolytic
uremic syndrome (HUS) worldwide [1–16]. In Europe,
the proportion of EHEC O26 among all EHEC patients´
isolates has been increasing during past years [1] and in
some countries, EHEC O26 is a more frequent cause of
HUS than EHEC O157:H7 [12, 16]. HUS caused by
EHEC O26 can be as severe as that caused by EHEC
O157:H7 [13, 17–20] and there is no significant differ-
ence in the long-term outcome of HUS caused by EHEC
O26 and EHEC O157 [18]. In addition to sporadic cases,
multiple outbreaks caused by EHEC O26 have been
reported throughout the world [15, 21–30].
The majority of EHEC O26 clinical isolates carry genes
encoding Shiga toxins (Stx) of two major types including
Stx1a and/or Stx2a [9, 26, 27, 31–33]. However, a subset
of strains contain genes encoding Stx subtypes such as
Stx2d [34, 35], Stx2b [15], or Stx2f [36]. The presence of
stx2a and/or production of Stx2a alone is a predictor for
a severe disease including progression of the infection to
HUS [31]. The stx2a-harboring EHEC O26 belong to two
major multilocus sequence types (STs) ST21 or ST29,
whereas strains harboring stx1a alone or together with
stx2a belong to ST21 [9, 31]. The ST29 clade is consider-
ably heterogeneous and consists of several clonal line-
ages which differ by stx2 alleles and plasmid gene
profiles [9, 31, 37, 38]. A new highly virulent ST29 clone
harboring stx2a only was first reported in Germany in
the mid-1990s [33] and since then it has rapidly spread
throughout Europe [31]. Strains of this lineage termed a
“new German clone” or a “new European clone” [31, 38]
exhibit a particular plasmid virulence gene profile char-
acterized by the presence of EHEC-hlyA (encoding
EHEC hemolysin) and etpD (encoding a type II effector),
while katP (encoding catalase-peroxidase) and espP (en-
coding serine protease EspP) genes are absent [31, 33].
In 2015, a distinct ST29 clonal lineage harboring stx2a or
stx2d and lacking the plasmid-borne virulence genes
(EHEC-hlyA, katP, espP, etpD) was reported in France as
a “new French clone” [35, 38]. Recently, yet another
ST29 clone, which harbors stx2a only and differs from
both the European and French clone by plasmid viru-
lence gene profile (EHEC-hlyA+, katP-, espP+, etpD-)
emerged in Japan [9]. This Japanese clone (designated
ST29C1 clade) is phylogenetically unrelated to the new
European clone (ST29C2 clade) and the French clone
(ST29C3 clade) [9].
Although EHEC O26 are the most common cause of
pediatric HUS in the Czech Republic [12], the clonal
structure of these strains has not been investigated in
detail. The aim of this study was to analyze the phylo-
genetic relationships and clonal structure of EHEC O26
isolated from patients in the Czech Republic by using
whole genome sequencing (WGS) with a particular focus
on ST29 strains. To put these data into a global context,
the genomic sequences of the Czech isolates were
compared with those of EHEC O26 isolated in other
European countries and with E. coli O26 genomes
present in GenBank.
Results
Whole genome-based clonal structure of EHEC O26
population
Initially, we performed WGS of 16 EHEC O26 strains
isolated from patients with HUS or diarrhea without
HUS in the Czech Republic during the period of 2006–
2016. The STs and plasmid gene profiles were deter-
mined in silico from draft genome sequences. This re-
vealed the presence of both major O26 phylogenetic
lineages, ST21 (6 isolates) and ST29 (10 isolates), among
Czech isolates (Additional file 1: Table S1). Five of the
six ST21 strains harbored stx2a only, and one contained
stx1a only; all of them displayed a plasmid-borne viru-
lence gene profile (EHEC-hlyA+, katP+, espP+, etpD-)
previously identified in ST21 strains [31] (Additional file
1: Table S1). Nine of the ten ST29 EHEC O26 Czech
strains corresponded to the new European clone (nEC)
as defined in [31], i.e., they contained stx2a as the sole
stx gene and the plasmid virulence gene profile EHEC--
hlyA+, katP-, espP-, and etpD+ (Additional file 1: Table
S1). Remarkably, the remaining ST29 strain (15–496)
harbored the plasmid gene profile typical for the nEC,
but combined with the presence of stx1c gene only in-
stead of stx2a (Additional file 1: Table S1). This is, to the
best of our knowledge, the first report of stx1c genotype
in strains of the nEC. To gain a more detailed insight into
the population structure of the nEC, we performed add-
itional WGS of a collection of European nEC isolates in-
cluding 16 strains originating from Germany (n = 11),
Italy (n = 3), and Austria (n = 2). For comparison, genomic
sequences of E. coli O26 available in the GenBank data-
base were included in this analysis, making up the final set
of total 159 E. coli O26 isolates whose genetic relation-
ships were examined (Additional file 1: Table S1).
A genome-wide single nucleotide polymorphism
(SNP)-based phylogram was constructed using the max-
imum likelihood model to provide high-resolution infer-
ence of E. coli O26 phylogeny (Fig. 1, Additional file 2:
Figure S1). This phylogram clearly identified four major
lineages, whose characteristics (i.e. ST, plasmid gene
profile, and predominant Stx type) were in accordance
with previous reports [9, 37–39]. Strikingly, the phylo-
genetic analysis demonstrated that strains of the nEC
(syn. ST29C2 [9]) split into two distinct clusters (Fig. 2).
This is in accordance with the observation of two dis-
tinct pulse-field gel electrophoresis (PFGE) clusters
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among a large, representative collection of European ST29
strains isolated between 1996 and 2012 in the original de-
scription of the nEC [31]. Retrospectively, we noted tenta-
tive differences between the two ST29 PFGE clusters with
respect to the distribution of isolation dates of the corre-
sponding strains. First strains of PFGE cluster B were
isolated as early as in 1996 and their majority (53.6%) until
2004. In contrast, strains of the PFGE cluster C started to
emerge, with a single exception, since 2004 [31]. We
therefore propose to name the WGS lineages homologous
to the PFGE clusters B and C as “early” and “late” nEC,
respectively (Fig. 2, Additional file 3: Table S3). This
designation is further supported by a detailed analysis of a
temporal shift between the nEC lineages, as shown below.
Evolution, diversification and spread of the nEC
To infer which genetic events underlied the evolutionary
establishment of the nEC and its subsequent split into
the “early” and “late” lineages, we sought mutations
characteristic for particular lineages, i.e., SNPs absent in
other E. coli O26 phylogroups including ST21 and ST29
non-nEC strains (synapomorphic mutations; for details,
see Methods). The sets of synapomorphic mutations
detected by this approach (Additional file 4: Table S2)
provide an unambiguous genetic definition of the par-
ticular nEC lineages. The total numbers of SNPs synapo-
morphic for early nEC, late nEC and nEC as a whole
were 59, 70, and 83, respectively (Fig. 2). This justifies
that the early nEC and late nEC should be considered
distinct phylogenetic entities. Next, we focused on
parallel evolution of missense synapomorphic mutations
(which are likely to influence function of encoded pro-
teins) within the nEC. Three cases where a single gene
underwent multiple amino acid changes during various
phases of nEC evolution were detected: cation trans-
porter CusA and hypothetical proteins YehI and YggM
accumulated two mutations each. Four operons accumu-
lated two missense mutations each: glgBXCAP (glycogen
metabolism), wza-wzb-wzc (capsular polysaccharide
synthesis), hisJQMP (histidine transport) and gcl-hyi-glx-
R-ybbW-allB-ybbY-glxK (purine metabolism) (Additional
file 4: Table S2). Notably, three mutations in fimbrial
biogenesis proteins (ElfG, YqiG, and HtrE) accounted
for 12% of 25 missense mutations synapomorphic for
the late nEC (Additional file 4: Table S2). Since fimbriae
are determinants of bacterial adherence, their modifica-
tion might affect persistence of late nEC strains in mam-
mal hosts or even pathogenesis in infected humans.
To rapidly differentiate between early nEC and late
nEC strains, we designed a simple SNP-based PCR,
which discriminates a mutation in the sen/ent gene (en-
coding Shigella flexneri enterotoxin 2 [40]), which is
synapomorphic for the late nEC (Additional file 4: Table
S2) (see Methods). This PCR was applied to screen all
nEC isolates originating from Germany and the Czech
Republic (45 and 15 isolates, respectively; Additional file
3: Table S3). Despite the limited numbers of isolates, a
trend of the early nEC decline with a concomitant in-
crease in the late nEC proportion was observed in both










ST29C3 (New French clone)
plasmid profile: -/-/-/- (10/10)
Shiga toxin: Stx2a (2/10), Stx2d (3/10)
ST29C1 (Japanese clone)
plasmid profile: +/-/+/- (12/12)
Shiga toxin: Stx2a (8/12)
ST29C2 (New European clone)
plasmid profile: +/-/-/+ (40/41)
Shiga toxin: Stx2a (39/41)
ST21
plasmid profile: +/+/+/- (65/95)
Shiga toxin: Stx1a (77/95)
C792_92
Fig. 1 Global population structure of E. coli O26 based on whole genome phylogeny. The major lineages are named according to the current convention
[9, 39]; strain C792_92 did not group within any lineage. The proportions of strains carrying plasmid gene profile characteristic for particular lineage (EHEC-
hlyA/katP/espP/etpD) are denoted in parentheses. Predominant type of Shiga toxin and its proportion among strains of each particular lineage are denoted
in parentheses. Core genome phylogeny was constructed from 12,205 variable bases among 3,718,610 validated homologous nucleotide positions.
Phylogenetic tree was constructed with FastTree using approximately Maximum Likelihood phylogeny model [60]. Genomic sequence of E. coli O111:H−
strain 11128 (stripped of plasmids, prophages and other horizontally acquired regions [68]) was used as an outgroup. For additional information about
particular strains, see Additional file 1: Table S1. For a complete (unreduced) phylogram, see Additional file 2: Figure S1
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might occupy the same niche and compete with each
other. The emergence of the late nEC in Germany (regu-
larly isolated since 2004) preceded its first occurrence in
the Czech Republic (2013) by nine years (Fig. 3). Strains
belonging to the late nEC were also isolated in several
other European countries including Austria (2008), Italy
(2008, 2010), France (2013), Netherlands (2013) and
Norway (2014), as well as in Japan (2008) (Fig. 2), which
documents the pan-European and inter-continental dis-
tribution of this lineage.
nEC strains harbor different stx2a-converting prophages
Shiga toxins encoded by stx genes are responsible for sys-
temic complications of EHEC infections such as HUS.
The stx genes are located in the genomes of lambdoid
prophages (stx-converting phages) which are very hetero-
geneous (reviewed in [41]). A recent report [38] demon-
strated that stx2a-converting prophages of EHEC O26 nEC
strains were virtually identical with the stx2a-prophages
present in the highly virulent E. coli O104:H4 German
outbreak strain [42], while other O26 lineages harbored
different stx-converting prophages [38]. To gain a deeper
characterization of these elements in the early nEC and
late nEC strains, we analyzed stx-converting prophages in
all nEC genomes sequenced in this study, utilizing short
sequencing reads and complete prophage sequences as
references (Fig. 4). All stx2a-converting prophages in nEC
strains were integrated into the wrbA gene which is also
the site of phage integration in E. coli O104:H4 [43] and
EHEC O157:H7 prototype strains Sakai [44] and EDL933
[45]. In agreement with Delannoy et al. [38], our results
demonstrate that stx2a-converting prophages virtually
identical with E. coli O104:H4 prophage (termed here
“type I”) are predominant among nEC isolates. Unexpect-
edly, another distinct type of stx2a-converting prophage
(termed here “type II”) was identified in four late nEC
strains (Fig. 2). While the left half (5´-portion) of the type
II prophage sequence was identical with O104:H4 pro-
phage, the right half (3´-portion) diverged significantly






CZ 2013 273A T type II
CZ 2014 WT type I
CZ 2016 WT type I
GER 2006 WT type I
AUS 2008 WT type I
CZ 2015 Stx1c absent
NOR 2014 WT n.d.
IT 2008 WT type I
IT 2008 WT n.d.
GER 2005 WT type I
NE 2013 WT n.d.
GER 2009 WT type I
GER 2012 273A T type II
GER 2007 WT type I
GER 2006 WT type I
GER 2000 WT other
GER 2004 273A T type II
GER 2010 WT type I
CZ 2013 273A T type II
CZ 2014 WT type I
IT 2010 WT type I
GER 2008 WT type I
AUS 2009 WT other
FR 2013 WT n.d.
CZ 2013 WT other
GER 2008 WT other
JAP 2008 WT n.d.
CZ 2009 WT type I
CZ 2009 WT type I
CZ 2010 WT other
NOR 2013 WT n.d.
IT 1999 WT n.d.
JAP 2013 WT n.d.
JAP 2012 WT n.d.
NOR 2002 x n.d.
NOR 2009 WT n.d.
NOR 2009 WT n.d.
NOR 2010 WT n.d.
NOR 2001 WT n.d.
NOR 2008 WT n.d.




































































































Fig. 2 Detailed whole-genome phylogeny of E. coli O26 nEC (ST29C2). Numbers and categories of SNPs synapomorphic for early nEC, late nEC or
nEC in general (Additional file 4: Table S2) are indicated above particular branches. Strains sequenced in this study are denoted in green, strains
whose genomic sequences were obtained from other sources are denoted in blue. Nodes supported by both FastTree and Neighbor-Joining
methods of tree inference are denoted with asterisks. Countries of origins are abbreviated as follows: AUS, Austria; CZ, Czech Republic; FR, France;
GER, Germany; IT, Italy; JAP, Japan; NE, Netherlands; NOR, Norway. The type of stx2a-converting prophage present in particular strain is indicated as
in Fig. 4; strains exhibiting significant deviations from coverage pattern and/or mutational pattern characteristic for type I or type II prophages are
denoted as “other”. Types of stx2a-converting prophages were not determined for whole genome assemblies obtained from other sources (n.d.).
Amino acid change in Stx2a (273A→ T) specific for type II prophages is denoted. Core genome phylogeny was constructed from 1,258 variable
bases among 4,332,095 validated homologous nucleotide positions. Phylogenetic tree was constructed with FastTree using approximately
Maximum Likelihood phylogeny model [60]. Genomic sequence of E. coli O26:H11 strain 11368 (stripped of plasmids, prophages and other
horizontally acquired regions [68]) was used as an outgroup
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sequencing reads to the O104:H4 prophage reference were
extracted from the divergent regions and searched against
the BLAST database of complete E. coli genomes. The
most closely related sequences were retrieved for stx2a--
converting prophages from EHEC O157:H7 [46]; the high
level of homology was confirmed by re-mapping of the se-
quencing reads to the O157:H7 prophage reference (Fig.
4). The presence of two DNA segments highly homolo-
gous to either O104:H4 or O157:H7 stx2a-converting pro-
phages suggests a role of recombination in the evolution
of type II prophages. This is in agreement with the view of
recombination as the most common genetic event con-
tributing to the mosaic structure and thus to the high gen-
etic diversity of EHEC stx-converting phages [38, 41].
Remarkably, the type II prophages carry a single point
mutation in the left half of their sequence, which is
otherwise identical among type I, type II and O104
stx-converting prophages (Fig. 4). This mutation, which
changes alanine (A) 273 into threonine (T) 273 in Stx2a
A subunit (Fig. 2), is novel among the known diversity
of Stx2 proteins and complements other mutations of
A273 to amino acids with hydroxylated side chains
(serine [S]and tyrosine [Y]- Additional file 5: Figure S2).
Stx production and cytotoxicity of nEC strains
To determine whether or not the A273→T273 mutation
in Stx2a A subunit encoded by the type II stx2a-prophages
influenced the toxicity of the resulting Stx2a protein, we
compared the amounts, Vero cell cytotoxicity titers, and
specific activities (CD50/ng toxin) of Stx2a produced by
nEC strains harboring the type II prophages with those of
strains harboring the type I or other stx2a-converting pro-
phages. No significant differences were found (Fig. 5), in-
dicating that the A273→T273 mutation in the type II
stx2a-prophage had no effect on Stx2a biological activity.
Moreover, comparison of Stx2a amounts, cytotoxicity
titers, and Stx2a specific activities between strains of the
late nEC and early nEC did not reveal any differences in
these characteristics within the ST29 nEC group (Fig. 5).
However, all these characteristics of ST29 nEC strains
were significantly higher than those of Stx2a-producing
strains of ST21 clonal group (Fig. 5).
Discussion
Using genome-wide SNP-based analysis, we demonstrate
that EHEC O26 strains belonging to the nEC are not
phylogenetically homogeneous, but consist of two distinct
lineages. This finding extends the present knowledge
about the clonal structure of these pathogens and con-
firms previous reports [9, 31, 35, 39] that E. coli O26:H11/
H− are, from the evolutionary point of view, highly dy-
namic with a potential for novel virulent clones to emerge
rapidly. Based on their consecutive appearance and spread
within Germany and the Czech Republic, we propose to
term these lineages “early” nEC and “late” nEC, respect-
ively. nEC was reported to have arisen in Germany during
the 1990s [31, 33]; currently, both nEC lineages are
widely distributed in Europe and were also isolated in Japan
(Fig. 2), which highlights that nEC strains are capable of
rapid spreading across countries and continents. Given the
genetic distinctness of the early and late nEC, their expan-
sions are likely to have occurred independently. Although
the spread via routes common to other EHEC (i.e. via live-
stock and/or food trade) seems to be most likely, E. coli
O26 corresponding to the nEC have only rarely been
isolated from cattle and other animals [47, 48]. Moreover,
none of 10 E. coli O26 nEC isolates (ST29C2 clade)
present among 520 whole genome sequences analyzed by
Ogura et al. [39], which represent a global population of
human and animal E. coli O26, originated from cattle or
other animals. Thus, reservoirs and possible ways of the
worldwide spread of E. coli O26 nEC in general and of the
1 1 2 1 3 3 3 13 2 1 6 2 1 1 3 3 5 4 4 1 5 2 2  nEC isolates
Germany 1996 - 2012 Czech Republic 2006 - 2016
0 0 0 0
Fig. 3 Annual incidence of early nEC and late nEC isolates in two Central European countries. The charts depict proportions of early nEC and late
nEC among nEC isolates (E. coli O26, ST29, EHEC-hlyA+, katP-, espP-, etpD+) collected in Germany and Czech Republic during time periods
indicated. Early nEC and late nEC isolates were discriminated by the sen/ent SNP-specific PCR (see Methods and Additional file 3: Table S3)
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late nEC in particular need to be further elucidated. This
is particularly important because of the increasing fre-
quency of the late nEC strains as causes of human diseases
in some European countries during last years (Fig. 3). To
create a basis for effective measures to control further
spread of these pathogens, screening of ST29 E. coli O26
isolates from cattle and other animals, using the sen/ent
SNP-based PCR developed in this study, combined with
plasmid gene profiling might be a useful and simple tool
for identification of strains of the early and late nEC.
Altogether, the emergence of the late nEC both throughout
and outside Europe supports a continuous evolution of E.
coli O26:H11/H− and a high propensity of new clones to
spread [9, 35, 39].
Analysis of stx2a-converting prophages in nEC strains
(Fig. 4) identified a predominant prophage (designated
type I), which displayed a nearly complete sequence iden-
tity with the stx2a-converting prophages of EHEC
O104:H4 strain, which caused the large devastating out-
break of HUS in Germany in 2011 [43]. Type I prophage
is widespread across the nEC diversity (Fig. 2), implicating
a single acquisition during early evolution of nEC (as also
suggested in [38]). Based on available bibliographic data,
the emergence of EHEC O26 nEC in the 1990s [31, 33]
predates the isolation of Stx2a-producing EHEC O104:H4
[32, 43, 49], which was first isolated in 2001 [32]. This
allows to speculate that EHEC O26 belonging to the nEC
might have served as donors of stx2a-converting phages
for enteroaggregative E. coli O104:H4 in the final step of
evolution of the highly virulent, Stx2a-producing EHEC
O104:H4 outbreak strain. Alternatively, EHEC O26 nEC
and EHEC O104:H4 outbreak strain might have acquired
their stx2a-converting phages independently from a com-
mon source. Beutin et al. [50] proposed that stx2a-convert-
ing prophages of EHEC O104:H4 might have originated
from stx2a-converting phages present among bovine E. coli
of various serotypes, with which they share nucleotide se-
quences of two specific DNA fragments, virion morph-
ology, DNA restriction patterns, chromosomal integration
site, and superinfection immunity [50]; however, this hy-
pothesis needs to be confirmed by complete sequence
analyses of the bovine phages.
Four late nEC strains were found to harbor a stx2a--
converting prophage whose sequence consisted of two
regions highly homologous to EHEC O104:H4 and
EHEC O157:H7 stx2a-phages, respectively (designed type
II; Fig. 4). These strains were scattered throughout the
whole-genome phylogenetic tree and their most closely
related strains harbored type I prophages (Fig. 2). This
provides evidence that horizontal, rather than vertical
pattern of type II prophages transfer was prevalent in
late nEC evolution, thus suggesting an ongoing dissem-
ination of type II phages in the E. coli O26 population.
Notably, Stx2a encoded by type II prophages contain a
novel amino acid change (A273→T273). This mutation
does not affect the potency of the toxin as demonstrated
by its specific activity for Vero cells, which is similar to
that of strains harboring type I prophages (Fig. 5).
Fig. 4 Different stx2a-converting prophages in EHEC O26 nEC strains. Visualization of sequencing reads mapped onto stx2a-converting prophages
from E. coli O104:H4 strain C227–11 (GenBank accession: CP011331; top) and E. coli O157:H7 strain Sakai (GenBank accession: NC_002695; bottom).
Strains 05–06154 and 13–194 represent the two distinct patterns of stx2a-converting prophages (type I and type II, respectively), which were
detected among EHEC O26 nEC strains (see Fig. 2). Green vertical lines represent true mutations with respect to reference sequence. Orange
vertical lines represent hybrid positions containing variant bases, which coincide with regions of abnormally high sequencing coverage (plausibly
representing contributions of sequencing reads from other lambdoid prophages [68])
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However, the localization of the mutation suggests a
possible connection with Stx2a maturation. A273 follows
immediately after arginine [R] 272; cleavage of Stx by
the Golgi protease furin takes place precisely between
these two residues [51, 52]. The cleavage generates the
enzymatically active form of Stx2a A subunit [53]. The
furin site where A273 binding takes place is a small
hydrophilic pocket [54], which could explain the propen-
sity of A273 for substitutions with hydroxyl-containing
amino acids (Additional file 5: Figure S2). If there are
any biological effects conferred by this Stx2a mutation
specific for type II prophages, remains to be elucidated.
Conclusions
Using genome-wide SNP-based analysis, this study pre-
sents the evidence of the split of the EHEC O26:H11/H−
nEC, which emerged in Germany in the 1990s and has
spread throughout Europe [31], into two cryptic, yet dis-
tinct clones (early nEC and late nEC, Fig. 2). For EHEC
O26, the combination of MLST, plasmid gene profiling
and PCR-based stx subtyping has been regarded as suffi-
cient for clone discrimination [9, 31]. The fact that
strains of the early nEC and late nEC are indistinguish-
able by this approach (Fig. 1) emphasizes the necessity
of using highly discriminatory methods such as the
genome-wide SNP-based analysis to distinguish the most
closely related epidemic lineages. For practical purposes,
the SNP-based PCR developed in this study which tar-
gets a mutation in the sen/ent gene synapomorphic for
the late nEC, represents a rapid and easy tool for distin-
guishing the early and late nEC strains in clinical micro-
biological laboratories and field studies. This will, in
turn, enable further investigations of the geographic dis-
tribution of these pathogens, their clinical significance,
and the epidemiology of human infections they cause.
Our results confirm that EHEC O26 nEC strains and
E. coli O104:H4 German outbreak strain [43] share the
same type of stx2a-converting prophage [38]. An add-
itional stx2a-converting prophage (type II), present in a
subset of the late nEC strains, displays several peculiar-
ities (hybrid sequence, novel missense mutation in stx2a,
multiple horizontal transmissions among late nEC)
which warrant further investigation.
In summary, the discriminatory power of whole gen-
ome sequencing allows for accurate reconstruction of
evolutionary events which accompanied the emergence
of novel clonal lineages of EHEC O26.
Methods
Database mining
Escherichia coli complete or draft genomic sequences






































































































































































Fig. 5 Stx2a production in nEC strains. The chart depicts Stx2a amounts, cytotoxicity titers, and specific activities of Stx2a produced by EHEC O26
ST29 late nEC strains harboring different types of stx2a-converting phages (as denoted in Fig. 2), ST29 early nEC strains and ST21 Stx2a-producing
strains. The data are means from four measurements. *p < 0.01 for comparisons between the indicated characteristics of ST21 strains and ST29
strains (one-way ANOVA)
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January 31st, 2017. The precompiled genome neighbors
of E. coli strain St. Olav179 (a member of late nEC, ac-
cession JZED00000000 [56]) were extracted. Strains with
symmetric identity below 92.0% were discarded since
they typically represented serotypes other than O26.
Among remaining strains, those belonging to non-O26
serotypes were discarded. In addition, genomic
sequences of strains included in later studies which
focused on genomic evolution of E. coli O26 [9, 38]
were included in the dataset. In total, 127 strains from
public sources were collected for genomic comparisons
(Additional file 1: Table S1).
Whole-genome sequencing
Sixteen EHEC O26:H11/H− strains were isolated from
patients with HUS (n = 10) or with bloody (n = 4) or
non-bloody (n = 2) diarrhea without HUS in the Czech
Republic between 2006 and 2016. Additional 16 EHEC
O26:H11/H− nEC strains sequenced in this study origi-
nated from Germany (n = 11), Italy (n = 3), and Austria
(n = 2) and were isolated from patients with HUS (n =
10) or non-bloody diarrhea (n = 6) (Additional file 1:
Table S1). The Czech and German strains were from the
authors´ laboratories. The Italian and Austrian iso-
lates were kindly provided by Stefano Morabito
(European Union Reference Laboratory for E. coli,
Instituto Superiore di Sanità, Rome, Italy) and Doro-
thea Orth-Höller (Division of Hygiene and Medical
Microbiology, Innsbruck Medical University, Austria),
respectively. WGS was performed as described previ-
ously [57]. Briefly, after inoculation of a single colony
into nutrient broth (Heipha, Eppelheim, Germany)
and overnight incubation (37 °C), genomic DNA was
extracted using a MagAttract HMW DNA kit (Qia-
gen, Hilden, Germany) with the addition of lysozyme
(Sigma-Aldrich, Taufkirchen, Germany) following the
manufacturer’s instructions. Subsequently, the sequen-
cing libraries were prepared from the genomic DNA
using the Nextera sample preparation kit (Illumina,
Inc., San Diego, CA, USA) for a 150-bp or 250-bp
paired-end sequencing run on a single MiSeq instru-
ment (Illumina) in accordance with the manufac-
turer’s recommendations. Libraries were scaled to
reach 100-fold sequencing coverage. Subsequent qual-
ity trimming and de novo assembly were performed
using the default parameters of CLC Genomics Work-
bench software (CLC bio, Arhus, Denmark) and the
CLC Genomics Workbench de novo assembler (CLC
bio). The draft genomes of strains sequenced in our
study were annotated using the NCBI prokaryotic
genome annotation pipeline [58] and are available in
the GenBank under the accession numbers listed in
Additional file 1: Table S1.
Bioinformatic analysis
Phylogeny reconstruction
Genome-wide SNP-based phylogeny was chosen for ro-
bust inference of E. coli O26 evolutionary history. Gen-
omic sequences were uploaded to the CSIPhylogeny v1.4
website (https://cge.cbs.dtu.dk/services/CSIPhylogeny/)
and automatically processed with default settings. SNP
analysis was carried out using a set of algorithms as de-
scribed in [59]; FastTree [60] was used for phylogram
construction. Phylogenetic trees were visualized using
MEGA7 [61]. Genomic sequences of E. coli O111:H−
strain 11128 and E. coli O26:H11 strain 11368 were
included as reference genomes for EHEC O26 and nEC
SNP-based phylogeny, respectively.
In silico analysis of molecular diagnostic markers
The presence of pathogenicity-related genes (plasmid
genes EHEC-hlyA, katP, espP and etpD, Shiga toxin
genes stx1a and stx2a) was assessed using TBLASTN [62]
integrated in Geneious R9.1 [63], using protein query
sequences from E. coli O26 strain 11368 (GenBank
accession: AP010953) or E. coli O157 strain Sakai
(GenBank accession: NC_002695). Presence or absence
and identity of encoded proteins with respect to query
sequences are listed in Additional file 1: Table S1.
Synapomorphic SNPs determination
Genomic sequences of several strains representing the
genomic diversity of E. coli O26 (early nEC: St. Olav174,
FHI24, FHI27; late nEC: ED676, St. Olav179, 36708,
STEC931; ST21: ED180, ED729, STEC1117, CVM9942,
non-nEC ST29: C792_92, CFSAN025102, 200C-3689,
34827) were aligned with Progressive MAUVE [64]. Pre-
sumptive synapomorphic SNPs (i.e. SNPs specific for
early nEC, late nEC or nEC in general) were manually
identified among the SNPs reported by MAUVE interge-
nomic comparison tool, based on their exclusive occur-
rence in corresponding lineages. For the definite
validation, BLAST search [65] was performed against all
genomic sequences included in the study (Additional file
1: Table S1); SNPs were considered synapomorphic if
they were present in all members of a particular lineage
and absent in all remaining O26 strains (Additional file
4: Table S2).
Stx-converting phage analysis
The paired-end sequencing reads were mapped onto
stx2a-converting prophage sequences present in E. coli
O104:H4 strain C227–11 (GenBank accession: CP011331)
and E. coli O157:H7 strain Sakai (GenBank accession:
NC_002695) using Geneious R9 platform [63]. The map-
ping setting was as follows: max. 20% gaps per read, max.
10% mismatches per read. SNPs (true mutations) were
called with coverage ≥5 and frequency ≥ 90% (with respect
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to the reference). Variable sites were called where a mix-
ture of bases was present in assembly of sequencing reads
(coverage ≥5, frequency of minor variant ≥30%).
Late nEC-discriminating PCR
A SNP-based PCR was used as a quick screening method
to detect a missense mutation in the sen/ent gene (encod-
ing Shigella flexneri enterotoxin 2), specific for late nEC
(102S→ Y; Additional file 4: Table S2). The following
primers were designed using Primer/BLAST [66]: forward
primer sen-F (5´-TCTAAATGGAAAGGTTAGTGATTG
C-3′) and reverse primer sen-RG (5´-GGTTATATA
TAACGCTTCCCCAAG-3′). In sen-RG, the 3′-terminal
guanine is not complementary to the late nEC-specific
SNP. The predicted amplicon length was 233 bp. PCR re-
actions were performed in CFX96 Touch PCR Detection
System (Bio-Rad) using reagents from Top-Bio (Czech Re-
public), primers obtained from Generi Biotech (Czech Re-
public) and bacterial lysates (boiling method) as DNA
templates. PCR conditions were: 94 °C for 5 min, followed
by 30 cycles of denaturation (94 °C for 30 s), annealing
(53 °C for 60 s), and extension (72 °C for 60 s) and a final
extension step at 72 °C for 5 min. One early nEC and one
late nEC strain were used as controls in each PCR. After
electrophoretic separation on agarose gel and ethidium
bromide staining, early nEC strains produced strong
amplicons, while late nEC strains displayed substantially
weaker amplicons due to a reduced pairing of 3′ guanine
with template DNA containing the SNP (Additional file 3:
Table S3). All nEC strains analyzed by WGS in this study
were tested with the late nEC-discriminating PCR; 100%
correlation between the sen/ent-specific PCR and WGS
results was achieved (Additional file 3: Table S3).
Detection of Stx production and cytotoxicity
VTEC RPLA
VTEC RPLA (Verotoxin-producing E. coli reverse passive
latex agglutination) assay (Denka Seiken Company, Ltd.,
Tokyo, Japan) was performed, according to the manufac-
turer’s instructions, with serially diluted sterile supernatants
prepared from overnight shaken broth cultures by centrifu-
gation (15 min, 4000 rpm, 4 °C) and subsequent filtration
through 0.22 μm syringe filters (P-LAB, Prague, Czech Re-
public). Stx1a and Stx2a titers were expressed as reciprocals
of the supernatants´ dilutions that produced a clear agglu-
tination of latex particles sensitized with anti-Stx1a and
anti-Stx2a antibody, respectively. Stx1a and Stx2a in the su-
pernatants were quantified by comparison of titers pro-
duced by the supernatants with those of Stx2a (VT2) and
Stx1a (VT1) standards with known toxin concentrations.
Vero cell assay
Vero-B4 cells (ACC-33; German collection of microor-
ganisms and cell cultures, Braunschweig, Germany) were
maintained in Dulbecco’s modified Eagle medium
(DMEM) with 4.5 g/l of glucose and glutamine (Lonza,
Cologne, Germany) supplemented with 10% of fetal bo-
vine serum (Sigma-Aldrich, Prague, Czech Republic). In
the cytotoxicity assay [67], semiconfluent Vero cell
monolayers grown in 96-well plates were incubated with
two-fold dilutions of supernatants prepared as above for
72 h. After removing medium with detached cells,
remnant adherent cells were fixed (2% formalin), stained
(0.13% crystal violet), washed, and after eluting of crystal
violet with 50% ethanol, absorbance (OD570) was mea-
sured by FLUOstar Omega (BMG Labtech, Ortenberg,
Germany). Cytotoxicity titers were expressed as recipro-
cal values of the sample dilutions that killed 50% of cells
(CD50). Specific activities of Stx in supernatants were
expressed as CD50/ng of Stx.
Statistical analysis
Data on Stx2a amounts, cytotoxicity titers, and specific
activities of Stx2a produced by different groups of strains
were analyzed with one-way analysis of variance
(ANOVA). p values < 0.05 were considered significant.
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